Ouvrages publiés à titre de seul auteur (1)
  1. 1. Dewachter, L. (2010). Pathobiologie de l’hypertension artérielle pulmonaire – Implication des voies de l’angiopoïétine et des protéines de morphogenèse osseuse dans le remodelage vasculaire. Editions universitaires européennes.
    2.   Parties d'ouvrages collectifs (3)
  2. 1. Dewachter, L. (2013). Prolonged overcirculation-induced pulmonary arterial hypertension, as a cause of right ventricular failure. In Treatment Strategies: Respiratory (pp. 63-65). eBook.
  3. 2. Dewachter, L., & Naeije, R. (2009). Animal models of pulmonary hypertension. In Advances in Pulmonary Hypertension (pp. 59-82). CRC Press.
  4. 3. Dewachter, L., & Naeije, R. (2009). Pulmonary Hypertension: Animal models of pulmonary arterial hypertension. In Pulmonary Hypertension, Vol. 236. Lung Biology in Health and Disease (pp. 59-82). M Humbert & JP Lynch.(Marcel Dekker).
    5.   Articles dans des revues avec comité de lecture (47)
  5. 1. Belhaj, A., Dewachter, L., Monier, A., Vegh, G., Rorive, S., Remmelink, M., Closset, M., Melot, C., Creteur, J., Salmon, I., & Rondelet, B. (2023). Beneficial Effects of Tacrolimus on Brain-Death-Associated Right Ventricular Dysfunction in Pigs. International Journal of Molecular Sciences (CD-ROM), 24(13), 10439. doi:10.3390/ijms241310439
  6. 2. Chomette, L., Hupkens, E., Romitti, M., Dewachter, L., Vachiery, J.-L., Bailly, S., Costagliola, S., Smits, G., Tillet, E., & Bondue, A. (2023). Pediatric pulmonary arterial hypertension due to a novel homozygous GDF2 missense variant affecting BMP9 processing and activity. American journal of medical genetics. Part A. doi:10.1002/ajmg.a.63236
  7. 3. Garcia, B., Su, F., Manicone, F., Dewachter, L., Favory, R., Khaldi, A., Moiroux-Sahroui, A., Moreau, A., Herpain, A., Vincent, J. L., Creteur, J., Taccone, F., & Annoni, F. (2023). Angiotensin 1-7 in an experimental septic shock model. Critical care, 27(1), 106. doi:10.1186/s13054-023-04396-8
  8. 4. El Oumeiri, B. G., Dewachter, L., Van De Borne, P., Hubesch, G., Melot, C., Jespers, P., Stefanidis, C., McEntee, K., & Vanden Eynden, F. (2023). Altered Left Ventricular Rat Gene Expression Induced by the Myosin Activator Omecamtiv Mecarbil. Genes, 14(1). doi:10.3390/genes14010122
  9. 5. Maruyama, H., Sakai, S., Dewachter, L., Dewachter, C., Rondelet, B., Naeije, R., & Ieda, M. (2023). Prostacyclin receptor agonists induce DUSP1 to inhibit pulmonary artery smooth muscle cell proliferation. Life sciences, 315, 121372. doi:10.1016/j.lfs.2023.121372
  10. 6. El Oumeiri, B. G., Van De Borne, P., Hubesch, G., Jespers, P., Dewachter, L., Stefanidis, C., McEntee, K., & Vanden Eynden, F. (2022). Detection of soluble suppression of tumorigenicity 2 and N-terminal B-type natriuretic peptide in a rat model of aortic regurgitation: differential responses to omecamtiv mecarbil. Journal of basic & clinical physiology & pharmacology, 33(6), 743-750. doi:10.1515/jbcpp-2022-0215
  11. 7. Belhaj, A., Dewachter, L., Hupkens, E., Remmelink, M., Galanti, L., Rorive, S., Melot, C., Naeije, R., & Rondelet, B. (2022). Tacrolimus Prevents Mechanical and Humoral Alterations in Brain Death-induced Lung Injury in Pigs. American journal of respiratory and critical care medicine, 206(5), 584-595. doi:10.1164/rccm.202201-0033OC
  12. 8. Garcia, B., Su, F., Dewachter, L., Favory, R., Khaldi, A., Moiroux-Sahraoui, A., Annoni, F., Vasques-Nóvoa, F., Rocha-Oliveira, E., Roncon-Albuquerque, R., Hubesch, G., Njimi, H., Vincent, J. L., Taccone, F., Creteur, J., & Herpain, A. (2022). Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock. Critical care, 26(1), 281. doi:10.1186/s13054-022-04161-3
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Suivant >>